Interferon_alpha-2b_injections_used_as_an_adjuvant_therapy_to_carbon_dioxide_laser_vaporization_of_recalcitrant_ano-genital_condylomata_acuminata._We_retrospectively_analyzed_our_treatment_of_men_with_anogenital_condylomata_acuminata_(CA)_at_Hennepin_County_Medical_Center_and_the_University_of_Minnesota._Between_October_1985_and_August_1989,_48_patients_with_CA_were_treated_with_laser_vaporization,_and_27_were_treated_with_laser_vaporization_followed_by_a_series_of_intralesional_interferon_(IFN)_alpha-2b_injections._The_patients_in_the_IFN_group_were_more_likely_to_have_perianal_CA_(44%_vs_24%),_had_larger_numbers_of_CA,_and_were_more_likely_to_have_had_previous_treatment,_including_previous_laser_vaporization._The_CA_in_the_laser_group_were_more_likely_to_be_on_the_penis_alone_(67%_vs_45%)_and_had_a_longer_mean_duration._The_laser-treated_group_experienced_a_38.2%_rate_of_recurrence_or_reinfection_with_a_mean_follow-up_period_of_13_weeks._The_laser_and_IFN_group_had_an_18.5%_rate_of_recurrence_or_reinfection_with_the_same_follow-up._We_conclude_that_intralesional_injections_of_alpha-2b_interferon_following_carbon_dioxide_laser_vaporization_of_recalcitrant_ano-genital_condylomata_substantially_reduce_the_risk_of_recurrence_or_reinfection.